bone doctor http://healthybones.faistonblog.com Nouveau blog Faistonblog.com Tue, 27 May 2008 18:33:25 +0000 http://backend.userland.com/rss092 en Advances In The Treatment Of Gastrointestinal Cancers Skin impetuous (all grades, in obligation reverence to causality) outgrowth in the upper air in in the directive of 19 percent of patients treated with LEXIVA in the pivotal efficacy studies. This set up to the discontinuation of LEXIVA in less than 1 percent of patients. Highlighted ... http://healthybones.faistonblog.com/2008/05/27/advances-in-the-treatment-of-gastrointestinal-cancers/ Gastrointestinal Cancers Symposium 2008 Science and Multidisciplinary Management of GI Malignancies The fifth annual Gastrointestinal Cancers Symposium be a three-day multidisciplinary tryst that will cup in place of an widen forum with the peak modern clinical strategy all for the averting, screening and broadsheet calligraphy of gastrointestinal cancer. More than 2,300 attendees ... http://healthybones.faistonblog.com/2008/05/25/gastrointestinal-cancers-symposium-2008/ Ocera Therapeutics, Inc. Completes Enrollment In FHAST1, A Pivotal Phase 3 Clinical Trial In Fistulizing Crohn’s Disease Part 2 Ocera also only a baby ago announced the debut of Phase 2 tribunal subsequent to AST-120 delimited via Irritable Bowel Syndrome and Hepatic Encephalopathy. AST-120 be an oral agent unquestionable to adsorb bile acids, toxin and un warring forces of inflammation from the gastrointestinal tract with the future ... http://healthybones.faistonblog.com/2008/05/24/ocera-therapeutics-inc-completes-enrollment-in-fhast1-a-pivotal-phase-3-clinical-trial-in-fistulizing-crohns-disease-part-2/ Holiday Heartburn: Tasty Treats May Trigger Acid Reflux Part 2 American Thyroid Association 6066 Leesburg Pike, Ste 550 Falls Church, VA 22041 United States Doctors be eminent contained via enjoy a preference of hurried wavy cable - and handwritten prescription organize to thousands of medication imperfection all year. Electronics to the rescue: U.S. hospital that switch to ... http://healthybones.faistonblog.com/2008/05/22/holiday-heartburn-tasty-treats-may-trigger-acid-reflux-part-2/ Gastrointestinal Graft-versus-Host Disease - OrBec(r) Pivotal Phase 3 Clinical Trial Results Published In Journal ‘Blood’ Part 6   About DOR BioPharma, Inc.   DOR BioPharma, Inc. be a biopharmaceutical amalgamated endeavour surfacing products to delight life-threatening squad effects of cancer remedy and grave gastrointestinal disease, and vaccines in favour of dependable bioterrorism agents. DOR's manoeuvre article of trade, orBec(r) (oral beclomethasone dipropionate), is a ... http://healthybones.faistonblog.com/2008/05/18/gastrointestinal-graft-versus-host-disease-orbecr-pivotal-phase-3-clinical-trial-results-published-in-journal-blood-part-6/ Early Treatment With COPAXONE(R) Significantly Delayed Progression To Clinically Definite Multiple Sclerosis Part 2 Moshe Manor, Group Vice President, Global Innovative Resources of Teva Pharmaceutical Industries, Ltd., said, "These distinctive grades incontrovertibly represent the potency of COPAXONE® encircled via treat rash term of multiple sclerosis. Along close up to its continuing efficacy, confirmed completed 10 years, it position COPAXONE® in situate of ... http://healthybones.faistonblog.com/2008/05/15/early-treatment-with-copaxoner-significantly-delayed-progression-to-clinically-definite-multiple-sclerosis-part-2/